Back to Agenda
Session 1: Optimizing Use of Personalized Medicine and Diagnostics for Patients
Session Chair(s)
Mark Stewart, PhD
Vice President, Science Policy
Friends of Cancer Research, United States
Clinical diagnostics and biomarker discoveries are advancing rapidly and increasingly being utilized to direct patient care. The development of predictive biomarkers is complex and the non-systematic approach to biomarker development and oversight can lead to challenges for regulators, patients, and physicians. This session will discuss challenges including the need for appropriate standards to support the use of high-quality tests, awareness and education, and value and access to inform key opportunities to support the use of diagnostics and personalized medicine and improve patient care.
Learning Objective : At the conclusion of this session, participants should be able to:
- Identify key concerns and challenges experienced by the patient community
- Discuss ongoing efforts to address key challenges to facilitate the use of high-quality diagnostic tests
- Describe mechanisms to integrate patient centricity into the development of diagnostic tests
Speaker(s)
Speaker
Andrea Stern Ferris, MBA
LUNGevity Foundation, United States
President and CEO
Speaker
Carolyn Hiller, MBA
Medical Device Innovation Consortium, United States
Program Director, Clinical Diagnostics
Speaker
Cynthia A Bens
Personalized Medicine Coalition, United States
Senior Vice President, Public Policy
Speaker
Nicola Normanno, MD
INT-Fondazione Pascale, Italy
Chief of the Cell Biology and Biotherapy-Unit
Have an account?